{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:26:41Z","timestamp":1784809601016,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12035-024-04377-0","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T13:02:33Z","timestamp":1722517353000},"page":"2203-2211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficiency of Cysticidal Therapy Impacted by the Host\u2019s Immune Response in Neurocysticercosis Patients"],"prefix":"10.1007","volume":"62","author":[{"given":"Yashvi","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upninder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Shree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paramjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"key":"4377_CR1","doi-asserted-by":"publisher","first-page":"615703","DOI":"10.3389\/fvets.2021.615703","volume":"8","author":"C Butala","year":"2021","unstructured":"Butala C, Brook TM, Majekodunmi AO, Welburn SC (2021) Neurocysticercosis: current perspectives on diagnosis and management. Front Vet Sci 8:615703","journal-title":"Front Vet Sci"},{"issue":"17","key":"4377_CR2","first-page":"169","volume":"97","author":"World Health Organization","year":"2022","unstructured":"World Health Organization (2022) WHO Taenia solium endemicity map\u20132022 update\u2013Carte OMS d\u2019end\u00e9micit\u00e9 de Taenia solium\u2013Mise \u00e0 jour 2022. Weekly Epidemiol Rec 97(17):169\u2013172","journal-title":"Weekly Epidemiol Rec"},{"key":"4377_CR3","doi-asserted-by":"publisher","first-page":"120393","DOI":"10.1016\/j.jns.2022.120393","volume":"29","author":"R Ta","year":"2022","unstructured":"Ta R, Blond BN (2022) The prevalence of and contributors to neurocysticercosis in endemic regions. J Neurol Sci 29:120393","journal-title":"J Neurol Sci"},{"issue":"4","key":"4377_CR4","doi-asserted-by":"publisher","first-page":"e0008005","DOI":"10.1371\/journal.pntd.0008005","volume":"14","author":"UF Prodjinotho","year":"2020","unstructured":"Prodjinotho UF, Lema J, Lacorcia M et al (2020) Host immune responses during Taenia solium neurocysticercosis infection and treatment. PLoS Negl Trop Dis 14(4):e0008005","journal-title":"PLoS Negl Trop Dis"},{"key":"4377_CR5","unstructured":"World Health Organization (2021) WHO Guidelines on management of Taenia solium neurocysticercosis. World Health Organization"},{"key":"4377_CR6","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s00415-004-0437-9","volume":"251","author":"A Fleury","year":"2004","unstructured":"Fleury A, Dessein A, Preux PM, Dumas M, Tapia G, Larralde C, Sciutto E (2004) Symptomatic human neurocysticercosis: age, sex and exposure factors relating with disease heterogeneity. J Neurol 251:830\u2013837","journal-title":"J Neurol"},{"key":"4377_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00430-011-0207-0","volume":"201","author":"B S\u00e1enz","year":"2012","unstructured":"S\u00e1enz B, Fleury A, Chavarria A, Hernandez M, Crispin JC, Vargas-Rojas MI, Fragoso G, Sciutto E (2012) Neurocysticercosis: local and systemic immune-inflammatory features related to severity. Med Microbiol Immunol 201:73\u201380","journal-title":"Med Microbiol Immunol"},{"key":"4377_CR8","doi-asserted-by":"publisher","unstructured":"Panda AK, Pati BK (2014) Immune-inflammatory markers in massively disseminated cysticercosis. BMJ Case Rep 2014. https:\/\/doi.org\/10.1136\/bcr-2013-202710","DOI":"10.1136\/bcr-2013-202710"},{"issue":"1","key":"4377_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1586\/eri.10.150","volume":"9","author":"A Fleury","year":"2011","unstructured":"Fleury A, Carrillo-Mezo R, Flisser A, Sciutto E, Corona T (2011) Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther 9(1):123\u2013133","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"4","key":"4377_CR10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.lpm.2012.01.010","volume":"41","author":"P Guilpain","year":"2012","unstructured":"Guilpain P, Le Jeunne C (2012) Anti-inflammatory and immunosuppressive properties of corticosteroids. Press Med (Paris, France: 1983) 41(4):378\u201383","journal-title":"Press Med (Paris, France: 1983)"},{"key":"4377_CR11","first-page":"67","volume":"13","author":"PT Hamamoto Filho","year":"2022","unstructured":"Hamamoto Filho PT, Rodr\u00edguez-Rivas R, Fleury A (2022) Neurocysticercosis: a review into treatment options, indications, and their efficacy. Res Rep Trop Med 13:67","journal-title":"Res Rep Trop Med"},{"issue":"7\u20138","key":"4377_CR12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/14789450.2020.1829486","volume":"17","author":"N Arora","year":"2020","unstructured":"Arora N, Prasad A (2020) Taenia solium proteins: a beautiful kaleidoscope of pro and anti-inflammatory antigens. Expert Rev Proteomics 17(7\u20138):609\u2013622","journal-title":"Expert Rev Proteomics"},{"key":"4377_CR13","doi-asserted-by":"crossref","unstructured":"Kruger NJ (2009) The Bradford method for protein quantitation. The protein protocols handbook, pp 17\u201324","DOI":"10.1007\/978-1-59745-198-7_4"},{"key":"4377_CR14","doi-asserted-by":"crossref","unstructured":"Tuero I, Palma S, Cabeza F, Saleemi S, Rodriguez S, Gonzales I, Mayta H, Mahanty S, Garcia HH, Gilman RH (2015) Cysticercosis Working Group in Per\u00fa. A comparative study of peripheral immune responses to Taenia solium in individuals with parenchymal and subarachnoid neurocysticercosis. PLoS Neg Trop Dis 9(10):e0004143","DOI":"10.1371\/journal.pntd.0004143"},{"issue":"9","key":"4377_CR15","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","volume":"28","author":"S Nylen","year":"2007","unstructured":"Nylen S, Sacks D (2007) Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol 28(9):378\u2013384. https:\/\/doi.org\/10.1016\/j.it.2007.07.004","journal-title":"Trends Immunol"},{"issue":"5","key":"4377_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1089\/jir.2016.0135","volume":"37","author":"A Verma","year":"2016","unstructured":"Verma A, Prasad KN (2016) Cytokines in neurocysticercosis. J Interferon Cytokine Res 37(5):201\u2013207. https:\/\/doi.org\/10.1089\/jir.2016.0135","journal-title":"J Interferon Cytokine Res"},{"issue":"7","key":"4377_CR17","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1128\/IAI.69.7.4554-4560.2001","volume":"69","author":"BI Restrepo","year":"2001","unstructured":"Restrepo BI, Alvarez JI, C\u00e1rdenas G, Arias LF, Restrepo M (2001) Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile. Infect Immun 69(7):4554\u20134560. https:\/\/doi.org\/10.1128\/IAI.69.7.4554-4560.2001","journal-title":"Infect Immun"},{"issue":"9","key":"4377_CR18","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nri1686","volume":"5","author":"L Schofield","year":"2005","unstructured":"Schofield L, Grau GE (2005) Immunological processes in malaria pathogenesis. Nat Rev Immunol 5(9):722\u2013735. https:\/\/doi.org\/10.1038\/nri1686","journal-title":"Nat Rev Immunol"},{"key":"4377_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1146\/annurev.med.51.1.187","volume":"51","author":"AC White","year":"2000","unstructured":"White AC (2000) Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Annu Rev Med 51:187\u2013206. https:\/\/doi.org\/10.1146\/annurev.med.51.1.187","journal-title":"Annu Rev Med"},{"key":"4377_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00430-014-0345-2","volume":"203","author":"G C\u00e1rdenas","year":"2014","unstructured":"C\u00e1rdenas G, Fragoso G, Rosetti M, Uribe-Figueroa L, Rangel-Escare\u00f1o C, Saenz B, Hern\u00e1ndez M, Sciutto E et al (2014) Neurocysticercosis: the effectiveness of the cysticidal treatment could be influenced by the host immunity. Med Microbiol Immunol 203:373\u2013381","journal-title":"Med Microbiol Immunol"},{"issue":"9","key":"4377_CR21","doi-asserted-by":"publisher","first-page":"e326","DOI":"10.1093\/cid\/ciaa1128","volume":"72","author":"S Harrison","year":"2021","unstructured":"Harrison S, Thumm L, Nash TE, Nutman TB, O\u2019Connell EM (2021) The local inflammatory profile and predictors of treatment success in subarachnoid neurocysticercosis. Clin Infect Dis 72(9):e326\u2013e333","journal-title":"Clin Infect Dis"},{"key":"4377_CR22","doi-asserted-by":"crossref","unstructured":"Nash TE, Del Brutto OH, Butman JA, Corona T, Delgado-Escueta A, Duron RM, Evans CA, Gilman RH, Gonzalez AE, Loeb JA, Medina MT (2004) Calcific neurocysticercosis and epileptogenesis. Neurology 62(11):1934\u20138","DOI":"10.1212\/01.WNL.0000129481.12067.06"},{"issue":"3","key":"4377_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.clim.2005.04.008","volume":"116","author":"A Chavarr\u00eda","year":"2005","unstructured":"Chavarr\u00eda A, Fleury A, Garc\u00eda E, M\u00e1rquez C, Fragoso G, Sciutto E (2005) Relationship between the clinical heterogeneity of neurocysticercosis and the immuneinflammatory profiles. Clin Immunol 116(3):271\u2013278","journal-title":"Clin Immunol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04377-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04377-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04377-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T03:35:49Z","timestamp":1737948949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04377-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["4377"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04377-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4288121\/v1","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"assertion":[{"value":"18 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}